Stocks declined on Tuesday as wild weather stifled activity and led to low volume. By the end of the session, 1.4 billion shares had changed hands on the S&P 500, below its 10-day average volume of 2.1 billion. DSW (DSW) rose after topping profit estimates and expanding its margins over its fourth quarter. The shoe retailer earned 20 cents over the quarter, 4 cents higher than forecasts. Merchandise margins increased by 270 basis points to 40.4% at its namesake segment. AstraZeneca (AZN) climbed in afternoon trading after publishing positive data on its late-stage ovarian cancer study. Results from a Phase 3 clinical trial resulted in improvement in progression-free survival compared to a placebo. AirMethods (AIRM) agreed to an acquisition by American Securities. The latter offered $43 a share in an all-cash deal with a total value of around $2.5 billion.
More from Video
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.